Does NAD+ supplementation reverse aging?
Weak EvidenceNO
Weak evidence for anti-aging effects in humans. NAD+ precursors (NMN, NR) reliably increase blood NAD+ levels, but no human trials have demonstrated reversal of aging biomarkers, functional improvements, or lifespan extension. Animal data is promising but translation remains unproven.
The Verdict
Weak evidence for anti-aging effects in humans. NAD+ precursors (NMN, NR) reliably increase blood NAD+ levels, but no human trials have demonstrated reversal of aging biomarkers, functional improvements, or lifespan extension. Animal data is promising but translation remains unproven.
What the Evidence Shows
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme essential for cellular energy metabolism, DNA repair (via sirtuins and PARPs), and epigenetic regulation. NAD+ levels decline 40-60% with age in various tissues, and this decline is implicated in mitochondrial dysfunction and age-related disease in animal models. Supplementation with precursors—nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)—consistently raises blood NAD+ levels by 40-90% in human trials. In aged mice, NAD+ repletion improves mitochondrial function, insulin sensitivity, exercise capacity, and extends lifespan. However, human trials to date show only that NAD+ levels increase—not that aging reverses. No human RCT has demonstrated improvements in validated aging biomarkers (epigenetic clocks, telomere length, functional capacity), muscle function, cognitive performance, or cardiovascular health with NR or NMN supplementation. The gap between raising a biomarker and achieving clinical benefit remains the critical unsolved question.
Evidence Quality
1
Meta-Analyses
8
RCTs
5
Observational
Important Caveats
- ⚠️ Human trials confirm NAD+ levels increase but show no functional anti-aging benefits yet
- ⚠️ Animal-to-human translation of longevity interventions has a poor track record
- ⚠️ Optimal dose, precursor form (NR vs NMN), and duration are unknown
- ⚠️ Long-term safety data beyond 12 weeks is limited
- ⚠️ Concern about potential cancer promotion (NAD+ fuels rapidly dividing cells)
- ⚠️ Expensive supplements ($50-150/month) with unproven human benefits
Population Studied
Healthy middle-aged and older adults (40-75 years); some studies in overweight adults; extensive preclinical data in aged mice
Dosage
Human trials used NR 250-2000mg/day or NMN 250-1250mg/day; most commonly 500-1000mg/day
Duration
Human trials lasted 2-12 weeks; no long-term (>6 month) outcome data in humans
Supporting Studies (3)
Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging
ObservationalGomes AP, Price NL, Ling AJY, et al. · Cell (2013)
NAD+ decline with age disrupts SIRT1-HIF1α signaling in mice, causing mitochondrial dysfunction. Restoring NAD+ with NMN in aged mice reversed this decline and restored mitochondrial function to youthful levels within one week.
View paper (DOI) →Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
RCTMartens CR, Denman BA, Mazzo MR, et al. · Nature Communications (2018)
NR 1000mg/day for 6 weeks was well-tolerated and increased whole blood NAD+ by ~60% in healthy older adults. A trend toward reduced systolic blood pressure and aortic stiffness was observed but did not reach statistical significance.
View paper (DOI) →Effect of oral nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men
RCTIrie J, Inagaki E, Fujita M, et al. · Endocrine Journal (2020)
NMN 250mg/day for 10 weeks safely elevated blood NAD+ metabolites in healthy men without adverse effects. No significant changes in body composition, glucose metabolism, or other clinical parameters were observed.
View paper (DOI) →Contradicting Studies (1)
Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures
RCTElhassan YS, Kluckova K, Fletcher RS, et al. · Cell Reports (2019)
Despite successfully increasing skeletal muscle NAD+ metabolites in older adults, NR supplementation (1000mg/day for 21 days) produced no measurable improvements in mitochondrial function, muscle strength, or exercise performance.
Why this disagrees:
This study directly challenged the assumed causal chain: even when NAD+ is successfully restored in human tissue, the functional improvements seen in aged mice do not materialize. Raising NAD+ may be necessary but not sufficient for reversing age-related functional decline in humans.
Related Claims
Does caloric restriction extend human lifespan?
Weak EvidenceWeak evidence in humans: Caloric restriction dramatically extends lifespan in animals (worms, flies, mice), but human evidence is limited to biomarker improvements. No human study has proven lifespan extension.
Does fasting trigger autophagy in humans?
Moderate EvidenceModerate evidence that fasting upregulates autophagy at a cellular level. Animal studies are unambiguous — fasting dramatically increases autophagy. In humans, recent trials measuring LC3 markers in blood cells show fasting does increase autophagic flux, but the health implications and optimal protocols remain unclear.
Does resveratrol slow aging in humans?
Weak EvidenceResveratrol dramatically extended lifespan in yeast, worms, and mice on high-fat diets. Human trials have shown minimal effects on aging biomarkers at doses achievable through supplements or diet.